Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy of a Lipiodol Emulsion for the Embolization of Hypervascularizations in Patients With Knee Pain (LipioJoint1)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of primary inflammatory knee osteoarthritis of the target joint defined by a knee osteoarthritis according to the American College of Rheumatology (ACR) classification and a score ≥ 2 according to the classification of Kellgren and Lawrence~* Patient not eligible for surgery (or refusing surgery)~* Analog Visual Scale (VAS) pain ≥ 40 mm despite analgesic treatment for at least 3 months~* Failure or intolerance of treatment with NSAIDs and/or tramadol and/or acetaminophen, and/or failure or intolerance or patient refusing strong opioids medication (morphine, codeine)~* Failure or patient refusal of corticosteroid infiltration~* Patient who has signed an informed consent~Exclusion Criteria:~* Patient who is unable or unable to comply with the follow-up schedule~* Infiltration of target joint less than three months old~* Treated hyperthyroidism~* Traumatic injury, hemorrhage or bleeding less than 1 week old in the target joint~* Known arterial disease of the lower limbs stage ≥ 2 according to the classification of Leriche and Fontaine~* Known severe allergy to Lipiodol® and/or iodized contrast product~* Known severe kidney failure (creatinine clearance \< 30 ml/min)~* Pregnant or breastfeeding woman~* Patient not affiliated with a French Medicare~* Patient benefiting from legal protection~* Participation in another interventional research

- Gender: ALL
- Minimum Age: 35 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Embolization (Type: EXPERIMENTAL): Embolization of the inflammatory hypervascularization with a lipiodol emulsion

Based on this trial design, predict the completion outcome and termination type (if applicable).